Ondansetron Fresenius i.v. 4 mg/2 ml

Ondansetron Fresenius i.v. 4 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 63071. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 November 2013 and the authorisation is valid without a time limit. ATC code A04AA01 places the medicine in the group Antiemetics and antinauseants.

  • Dispensing category B
  • Authorisation number 63071
  • ATC A04AA01
  • Synthetic medicines
Authorisation data
Authorisation number63071
NameOndansetron Fresenius i.v. 4 mg/2 ml
Full nameOndansetron Fresenius i.v. 4 mg/2 ml, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA04AA01
First authorisation01 November 2013
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ondansetron Fresenius i.v. 4 mg/2 ml, Konzentrat zur Herstellung einer Injektions- /InfusionslösungB01 November 2013
2Ondansetron Fresenius i.v. 8 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungB01 November 2013

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15x2 mlAmpulle(n)A04AA0101.09.0.B
35x4mlAmpulle(n)A04AA0101.09.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ondansetron Fresenius i.v. 4 mg/2 ml authorised in Switzerland?

Yes. Ondansetron Fresenius i.v. 4 mg/2 ml is authorised by Swissmedic under authorisation number 63071, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ondansetron Fresenius i.v. 4 mg/2 ml have?

Ondansetron Fresenius i.v. 4 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ondansetron Fresenius i.v. 4 mg/2 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com